As of 2025-09-17, the Relative Valuation of Intra-Cellular Therapies Inc (ITCI) is (13.78) USD. This relative valuation is based on P/E multiples. With the latest stock price at 131.87 USD, the upside of Intra-Cellular Therapies Inc based on Relative Valuation is -110.4%.
The range of the Relative Valuation is (13.36) - (13.96) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.7x - 19.9x | 18.8x |
| Forward P/E multiples | 19.1x - 21.7x | 20.5x |
| Fair Price | (13.36) - (13.96) | (13.78) |
| Upside | -110.1% - -110.6% | -110.4% |
| Date | P/E |